GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by it to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSKs vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc Key Recent Developments

Oct 29,2018: GSK announces positive phase 3 results for daprodustat in patients with anaemia associated with chronic kidney disease
Oct 25,2018: GSK opens new Ellipta plant in Scotland
Oct 23,2018: MBDA, GSK and Airbus team up for Generation Stevenage event
Oct 23,2018: GlaxoSmithKline opens new 54 million facility in north-east town
Oct 22,2018: GSK invests in Montrose

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 5
List of Figures 5
Section 1 - About the Company 6
GlaxoSmithKline Plc - Key Facts 6
GlaxoSmithKline Plc - Key Employees 7
GlaxoSmithKline Plc - Key Employee Biographies 8
GlaxoSmithKline Plc - Major Products and Services 9
GlaxoSmithKline Plc - History 12
GlaxoSmithKline Plc - Company Statement 38
GlaxoSmithKline Plc - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Joint Venture 53
Section 2 Company Analysis 55
Company Overview 55
GlaxoSmithKline Plc - Business Description 56
Business Segment: Consumer Healthcare 56
Overview 56
Performance 56
Key Stats 56
Business Segment: Pharmaceuticals 57
Overview 57
Performance 57
Key Stats 57
Business Segment: Vaccines 57
Overview 57
Performance 58
Key Stats 58
Geographical Segment: International 58
Performance 58
Geographical Segment: The UK 58
Performance 58
Geographical Segment: US 58
Performance 58
R&D Overview 58
GlaxoSmithKline Plc - Corporate Strategy 60
GlaxoSmithKline Plc - SWOT Analysis 61
SWOT Analysis - Overview 61
GlaxoSmithKline Plc - Strengths 61
GlaxoSmithKline Plc - Weaknesses 62
GlaxoSmithKline Plc - Opportunities 63
GlaxoSmithKline Plc - Threats 64
GlaxoSmithKline Plc - Key Competitors 65
Section 3 Company Financial Ratios 66
Financial Ratios - Capital Market Ratios 66
Financial Ratios - Annual Ratios 67
Performance Chart 70
Financial Performance 70
Financial Ratios - Interim Ratios 71
Financial Ratios - Ratio Charts 72
Section 4 Companys Lifesciences Financial Deals and Alliances 73
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 73
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 74
GlaxoSmithKline Plc, Recent Deals Summary 75
Section 5 Companys Recent Developments 76
Oct 22, 2018: GlaxoSmithKline Pharmaceuticals delivers strong H1 performance; H1 Revenue up 8% and PAT higher by 21% 76
Oct 22, 2018: GSK invests in Montrose 78
Oct 21, 2018: GSK presents new efficacy and safety data of an anti GM-CSF antibody in patients with rheumatoid arthritis 80
Oct 18, 2018: 18 October 2018 ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV Priority review voucher used with NDA submission with anticipated target action date of six mont 83
Oct 18, 2018: 18 October 2018 ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV Priority review voucher used with NDA submission with anticipated target action date of six mont 92
Oct 18, 2018: 18 October 2018 ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV Priority review voucher used with NDA submission with anticipated target action date of six mont 101
Oct 18, 2018: 18 October 2018 ViiV Healthcare submits New Drug Application to US FDA for single-tablet, two-drug regimen of dolutegravir and lamivudine for treatment of HIV Priority review voucher used with NDA submission with anticipated target action date of six mont 110
Oct 02, 2018: GSK updates policy for working with healthcare professionals 119
Oct 02, 2018: GSK updates policy for working with healthcare professionals 120
Oct 01, 2018: Theraflu PowerPods launches Pods For convenient cold and flu symptom relief 121
Section 6 Appendix 122
Methodology 122
Ratio Definitions 122
About GlobalData 126
Contact Us 126
Disclaimer 126

List Of Tables


GlaxoSmithKline Plc, Key Facts 6
GlaxoSmithKline Plc, Key Employees 7
GlaxoSmithKline Plc, Key Employee Biographies 8
GlaxoSmithKline Plc, Major Products and Services 9
GlaxoSmithKline Plc, History 12
GlaxoSmithKline Plc, Other Locations 40
GlaxoSmithKline Plc, Subsidiaries 41
GlaxoSmithKline Plc, Joint Venture 53
GlaxoSmithKline Plc, Key Competitors 65
GlaxoSmithKline Plc, Ratios based on current share price 66
GlaxoSmithKline Plc, Annual Ratios 67
GlaxoSmithKline Plc, Annual Ratios (Cont...1) 68
GlaxoSmithKline Plc, Annual Ratios (Cont...2) 69
GlaxoSmithKline Plc, Interim Ratios 71
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 73
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 74
GlaxoSmithKline Plc, Recent Deals Summary 75
Currency Codes 122
Capital Market Ratios 122
Equity Ratios 123
Profitability Ratios 123
Cost Ratios 124
Liquidity Ratios 124
Leverage Ratios 125
Efficiency Ratios 125

List Of Figures


GlaxoSmithKline Plc, Performance Chart (2013 - 2017) 70
GlaxoSmithKline Plc, Ratio Charts 72
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 73
GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 74

GlaxoSmithKline Plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

GlaxoSmithKline Plc (GSK) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV,

USD 250 View Report

GlaxoSmithKline Plc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

GlaxoSmithKline Plc (GSK) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV,

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available